NCT00179114View on ClinicalTrials.gov

Vanderbilt University Spasticity Management Program Evaluation Plan

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

February 28, 2006

Conditions

Spasticity

Interventions

DRUG

Botulinum Toxin Type A

DRUG

Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB)

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

Sponsors

Collaborators (2)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Vanderbilt University

OTHER